一步法和两步法乳房重建相关比较研究

孙铭君; 尹健

doi:10.12354/j.issn.1000-8179.2023.20230511

一步法和两步法乳房重建相关比较研究

doi: 10.12354/j.issn.1000-8179.2023.20230511

孙铭君,
尹健^,

天津医科大学肿瘤医院乳房再造科，国家恶性肿瘤临床医学研究中心，天津市恶性肿瘤临床医学研究中心，乳腺癌防治教育部重点实验室，天津市“肿瘤防治”重点实验室, 中俄乳腺肿瘤整形联合研究中心（天津市300060）

基金项目: 本文课题受天津市医学重点学科（专科）建设项目（编号：TJYXZDXK-009A）和天津市“项目+团队”重点培养专项基金项目（编号：XB202008）资助

详细信息

作者简介:
孙铭君：专业方向为乳腺肿瘤临床治疗及乳房重建等

通讯作者:
尹健　yinjian@tjmuch.com

计量
- 文章访问数: 29
- HTML全文浏览量: 9
- PDF下载量: 12
- 被引次数: 0
出版历程
- 收稿日期: 2023-06-07
- 录用日期: 2023-10-25
- 修回日期: 2023-10-20

Comparative study of direct-to-implant and two-stage tissue expander/implant breast reconstruction

Mingjun Sun,
Jian Yin^,

Department of Breast Reconstruction and Oncoplastic Surgery, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin′s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Key Laboratory of Cancer Prevention and Therapy, Sino‐Russian Joint Research Center for Oncoplastic Breast Surgery, Tianjin 300060, China

Funds: This work was supported by Tianjin Key Medical Discipline (Specialty) Construction Project (No. TJYXZDXK-009A) and Tianjin Special Foundation for Project and Team Development Grant (No. XB202008)

More Information

Corresponding author: Jian Yin; E-mail: yinjian@tjmuch.com

摘要

摘要: 乳腺癌是我国女性最常见的恶性肿瘤。乳房切除术是乳腺癌患者常选择的治疗方法，在延长患者生存期的同时也给乳腺癌患者带来极大的心理创伤和精神压力。假体重建是目前临床上常用的乳房重建方法，而关于一步法（direct-to-implant，DTI）重建和两步法（ two-stage tissue expander/implant，TE/I）重建的优劣仍无统一的结论。本文将就近年来DTI和TE/I在并发症、患者满意度和成本效益方面的比较研究进行综述。
- 乳腺癌 /
- 假体重建 /
- 一步法 /
- 两步法
Abstract: Breast cancer is the most common malignant tumor among Chinese women. Patients with breast cancer often choose breast mastectomy for prolonged survival. However, breast mastectomy causes severe psychological trauma and pressure. Notably, in clinical treatment, implant-based reconstruction has been frequently used for breast reconstruction. To date, there is no unified conclusion about the merits and demerits of direct-to-implant (DTI) and two-stage tissue expander/implant (TE/I) breast reconstruction. Herein, we present a comparative study of DTI and TE/I breast reconstruction with respect to complications, satisfaction, and cost incurred in recent years.
- breast cancer /
- implant-based reconstruction /
- direct-to-implant (DTI) /
- two-stage tissue expander/implant (TE/I)

HTML全文

参考文献(23)

[1]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. doi: 10.3322/caac.21660
[2]	Yin ZM, Wang Y, Sun JY, et al. Association of sociodemographic and oncological features with decision on implant-based versus autologous immediate postmastectomy breast reconstruction in Chinese patients[J]. Cancer Med, 2019, 8(5):2223-2232. doi: 10.1002/cam4.2133
[3]	熊敏,陈嘉健,吴炅.乳腺癌术后放疗对植入物重建不同技术策略的影响与思考[J].中国实用外科杂志,2021,41(11):1252-1256. doi: 10.19538/j.cjps.issn1005-2208.2021.11.13
[4]	谢嘉桁,史京萍,阮姝婕,等.植入物相关一步法和二步法乳房重建结局的荟萃分析[J].中国医学前沿杂志(电子版),2021,13(12):89-95.
[5]	中国抗癌协会乳腺癌专业委员会,中国医师协会外科医师分会乳腺外科医师委员会,上海市抗癌协会乳腺癌专业委员会.乳腺肿瘤整形与乳房重建专家共识(2022年版)[J].中国癌症杂志,2022,32(9):836-924.
[6]	José S, Francisco C, Marisa M. Direct-to-implant subcutaneous breast reconstruction: a systematic review of complications and patient’s quality of life[J]. Aesthetic Plast Surg, 2022, 47(1):92-105.
[7]	Sue GR, Sun BJ, Lee GK. Complications after two-stage expander implant breast reconstruction requiring reoperation: a critical analysis of outcomes[J]. Ann Plast Surg, 2018, 80(5S Suppl 5):S292-S294.
[8]	Dikmans RE, Negenborn VL, Bouman MB, et al. Two-stage implant-based breast reconstruction compared with immediate one-stage implant-based breast reconstruction augmented with an acellular dermal matrix: an open-label, phase 4, multicentre, randomised, controlled trial[J]. Lancet Oncol, 2017, 18(2):251-258. doi: 10.1016/S1470-2045(16)30668-4
[9]	Brunbjerg ME, Jensen TB, Overgaard J, et al. Comparison of one-stage direct-to-implant with acellular dermal matrix and two-stage immediate implant-based breast reconstruction-a cohort study[J]. Gland Surg, 2021, 10(1):207-218. doi: 10.21037/gs-20-581
[10]	Srinivasa DR, Garvey PB, Qi J, et al. Direct-to-implant versus two-stage tissue expander/implant reconstruction: 2-year risks and patient-reported outcomes from a prospective, multicenter study[J]. Plast Reconstr Surg, 2017, 140(5):869-877. doi: 10.1097/PRS.0000000000003748
[11]	李正东,成小林,武羿,等.女性乳腺癌全乳切除术后乳房假体一步法及两步法重建效果比较[J].同济大学学报(医学版),2020,41(6):754-759. doi: 10.16118/j.1008-0392.2020.06.012
[12]	Han HH, Kim HB, Kim EK, et al. Direct-to-implant as a frontline option for immediate breast reconstruction: a comparative study with 2-stage reconstruction[J]. Ann Plast Surg, 2018, 81(3):274-279. doi: 10.1097/SAP.0000000000001517
[13]	Orecchia R. Post-mastectomy radiotherapy reduces recurrence and mortality[J]. Nat Rev Clin Oncol, 2014, 11(7):382-384. doi: 10.1038/nrclinonc.2014.95
[14]	Du FZ, Liu RZ, Zhang HL, et al. Post-mastectomy adjuvant radiotherapy for direct-to-implant and two-stage implant-based breast reconstruction: a meta-analysis[J]. J Plast Reconstr Aesthet Surg, 2022, 75(9):3030-3040. doi: 10.1016/j.bjps.2022.06.063
[15]	Lin AM, Christensen JM, Liao EC, et al. Postmastectomy radiation therapy on permanent implants or tissue expanders: which is better[J]? Ann Surg, 2021, 274(6):e974-e979. doi: 10.1097/SLA.0000000000003670
[16]	Naoum GE, Salama L, Niemierko A, et al. Single stage direct-to-implant breast reconstruction has lower complication rates than tissue expander and implant and comparable rates to autologous reconstruction in patients receiving postmastectomy radiation[J]. Int J Radiat Oncol Biol Phys, 2020, 106(3):514-524. doi: 10.1016/j.ijrobp.2019.11.008
[17]	Jagsi R, Momoh AO, Qi J, et al. Impact of radiotherapy on complications and patient-reported outcomes after breast reconstruction[J]. J Natl Cancer Inst, 2018, 110(2):157-165. doi: 10.1093/jnci/djx148
[18]	司婧,吴炅.乳腺癌患者乳房重建术后满意度评估方法比较[J].中华乳腺病杂志(电子版),2017,11(6):361-364.
[19]	Negenborn VL, Young-Afat DA, Dikmans REG, et al. Quality of life and patient satisfaction after one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage breast reconstruction (BRIOS): primary outcome of a randomised, controlled trial[J]. Lancet Oncol, 2018, 19(9):1205-1214. doi: 10.1016/S1470-2045(18)30378-4
[20]	Innocenti A, Melita D, Affortunati M, et al. Immediate-implant-based-breast-reconstruction with two-stage expander-implant reconstruction versus one-stage-reconstruction with acellular dermal matrix: analysis of patients' satisfaction[J]. Acta Biomed, 2021, 92(3):e2021228.
[21]	Wang S, He S, Zhang X, et al. Acellular bovine pericardium matrix in immediate breast reconstruction compared with conventional implant-based breast reconstruction[J]. JPRAS Open, 2021, 29:1-9. doi: 10.1016/j.jpra.2021.03.005
[22]	Negenborn VL, Smit JM, Dikmans REG, et al. Short-term cost-effectiveness of one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage expander-implant reconstruction from a multicentre randomized clinical trial[J]. Br J Surg, 2019, 106(5):586-595. doi: 10.1002/bjs.11102
[23]	李宇翔,丰锦春,朱丽萍,等.植入物乳房重建一步法和二步法临床对比研究[J].现代肿瘤医学,2020,28(10):1668-1673. doi: 10.3969/j.issn.1672-4992.2020.10.013